Different approaches to modelling the cost-effectiveness of schistosomiasis control

This paper reviews three different approaches to modelling the cost-effectiveness of schistosomiasis control. Although these approaches vary in their assessment of costs, the major focus of the paper is on the evaluation of effectiveness. The first model presented is a static economic model which as...

Full description

Bibliographic Details
Main Author: Guyatt Helen
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 1998-01-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761998000700010
_version_ 1797757244628008960
author Guyatt Helen
author_facet Guyatt Helen
author_sort Guyatt Helen
collection DOAJ
description This paper reviews three different approaches to modelling the cost-effectiveness of schistosomiasis control. Although these approaches vary in their assessment of costs, the major focus of the paper is on the evaluation of effectiveness. The first model presented is a static economic model which assesses effectiveness in terms of the proportion of cases cured. This model is important in highlighting that the optimal choice of chemotherapy regime depends critically on the level of budget constraint, the unit costs of screening and treatment, the rates of compliance with screening and chemotherapy and the prevalence of infection. The limitations of this approach is that it models the cost-effectiveness of only one cycle of treatment, and effectiveness reflects only the immediate impact of treatment. The second model presented is a prevalence-based dynamic model which links prevalence rates from one year to the next, and assesses effectiveness as the proportion of cases prevented. This model was important as it introduced the concept of measuring the long-term impact of control by using a transmission model which can assess reduction in infection through time, but is limited to assessing the impact only on the prevalence of infection. The third approach presented is a theoretical framework which describes the dynamic relationships between infection and morbidity, and which assesses effectiveness in terms of case-years prevented of infection and morbidity. The use of this model in assessing the cost-effectiveness of age-targeted treatment in controlling Schistosoma mansoni is explored in detail, with respect to varying frequencies of treatment and the interaction between drug price and drug efficacy.
first_indexed 2024-03-12T18:13:05Z
format Article
id doaj.art-331e2540746a43c08773c15a23e50479
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T18:13:05Z
publishDate 1998-01-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-331e2540746a43c08773c15a23e504792023-08-02T09:14:10ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80601998-01-0193suppl.17584Different approaches to modelling the cost-effectiveness of schistosomiasis controlGuyatt HelenThis paper reviews three different approaches to modelling the cost-effectiveness of schistosomiasis control. Although these approaches vary in their assessment of costs, the major focus of the paper is on the evaluation of effectiveness. The first model presented is a static economic model which assesses effectiveness in terms of the proportion of cases cured. This model is important in highlighting that the optimal choice of chemotherapy regime depends critically on the level of budget constraint, the unit costs of screening and treatment, the rates of compliance with screening and chemotherapy and the prevalence of infection. The limitations of this approach is that it models the cost-effectiveness of only one cycle of treatment, and effectiveness reflects only the immediate impact of treatment. The second model presented is a prevalence-based dynamic model which links prevalence rates from one year to the next, and assesses effectiveness as the proportion of cases prevented. This model was important as it introduced the concept of measuring the long-term impact of control by using a transmission model which can assess reduction in infection through time, but is limited to assessing the impact only on the prevalence of infection. The third approach presented is a theoretical framework which describes the dynamic relationships between infection and morbidity, and which assesses effectiveness in terms of case-years prevented of infection and morbidity. The use of this model in assessing the cost-effectiveness of age-targeted treatment in controlling Schistosoma mansoni is explored in detail, with respect to varying frequencies of treatment and the interaction between drug price and drug efficacy.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761998000700010schistosomiasismathematical modellingcost-effectiveness analysiscontrolmorbidity
spellingShingle Guyatt Helen
Different approaches to modelling the cost-effectiveness of schistosomiasis control
Memorias do Instituto Oswaldo Cruz
schistosomiasis
mathematical modelling
cost-effectiveness analysis
control
morbidity
title Different approaches to modelling the cost-effectiveness of schistosomiasis control
title_full Different approaches to modelling the cost-effectiveness of schistosomiasis control
title_fullStr Different approaches to modelling the cost-effectiveness of schistosomiasis control
title_full_unstemmed Different approaches to modelling the cost-effectiveness of schistosomiasis control
title_short Different approaches to modelling the cost-effectiveness of schistosomiasis control
title_sort different approaches to modelling the cost effectiveness of schistosomiasis control
topic schistosomiasis
mathematical modelling
cost-effectiveness analysis
control
morbidity
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761998000700010
work_keys_str_mv AT guyatthelen differentapproachestomodellingthecosteffectivenessofschistosomiasiscontrol